SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells (Q40341738)

19 September 2017

title

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells (English)

1 reference

spike glycoprotein [SARS-Cov]

19 September 2017

main subject

human Coronavirus NL63

0 references

SARS-CoV-1

1 reference

based on heuristic

inferred from title

0 references

1 reference

human coronavirus

1 reference

Wenhui Li

4

0 references

Peter J M Rottier

12

object named as

Peter J M Rottier

1 reference

19 September 2017

2

Berend Jan Bosch

1 reference

19 September 2017

11

Michael Farzan

1 reference

19 September 2017

10

Philip R Dormitzer

1 reference

19 September 2017

9

Stephen C Harrison

1 reference

19 September 2017

I-Chueh Huang

1

1 reference

19 September 2017

Fang Li

3

1 reference

19 September 2017

Kyoung Hoa Lee

5

1 reference

19 September 2017

Sorina Ghiran

6

1 reference

19 September 2017

Natalya Vasilieva

7

1 reference

19 September 2017

Terence S Dermody

8

1 reference

19 September 2017

Hyeryun Choe

13

1 reference

19 September 2017

language of work or name

English

0 references

publication date

8 December 2005

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

3198-3203

1 reference

Aetiology: Koch's postulates fulfilled for SARS virus

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Human aminopeptidase N is a receptor for human coronavirus 229E

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Identification of a new human coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A previously undescribed coronavirus associated with respiratory disease in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Human coronavirus NL63 infection in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Detection of human coronavirus NL63 in young children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Coronavirus spike proteins in viral entry and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Virus entry: molecular mechanisms and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

The SARS-CoV S glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Lysosomal cysteine proteases: facts and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Cathepsin S supports acid-independent infection by some reoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Addition of exogenous protease facilitates reovirus infection in many restrictive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Disulfide Bonding among μ1 Trimers in Mammalian Reovirus Outer Capsid: a Late and Reversible Step in Virion Morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Cathepsin L is required for endothelial progenitor cell-induced neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508381200

21 January 2018

Identifiers

DOI

10.1074/JBC.M508381200

1 reference

19 September 2017

1 reference